Similar articles

• Biology of Alzheimer's disease.

  Haass C. Haass C. Eur Arch Psychiatry Clin Neurosci. 1999;249(6):265. doi: 10.1007/s004060050097. Eur Arch Psychiatry Clin Neurosci. 1999. PMID: 10653280 No abstract available.
• Reelin in plaques of beta-amyloid precursor protein and presenilin-1 double-transgenic mice.

  Wirths O, Multhaup G, Czech C, Blanchard V, Tremp G, Pradier L, Beyreuther K, Bayer TA. Wirths O, et al. Neurosci Lett. 2001 Dec 28;316(3):145-8. doi: 10.1016/s0304-3940(01)02399-0. Neurosci Lett. 2001. PMID: 11744223
• Alzheimer's disease: genotypes, phenotypes, and treatments.

  Selkoe DJ. Selkoe DJ. Science. 1997 Jan 31;275(5300):630-1. doi: 10.1126/science.275.5300.630. Science. 1997. PMID: 9019820 Review. No abstract available.
• Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease.

  Kobayashi DT, Chen KS. Kobayashi DT, et al. Genes Brain Behav. 2005 Apr;4(3):173-96. doi: 10.1111/j.1601-183X.2005.00124.x. Genes Brain Behav. 2005. PMID: 15810905 Review.
• Biological transgenic mouse models of Alzheimer's disease.

  Crews L, Rockenstein E, Masliah E. Crews L, et al. Handb Clin Neurol. 2008;89:291-301. doi: 10.1016/S0072-9752(07)01227-4. Handb Clin Neurol. 2008. PMID: 18631753 Review. No abstract available.